Clinical Study

Triptorelin in the Relief of Lower Urinary Tract Symptoms in Advanced Prostate Cancer Patients: The RESULT Study

Table 2

Evolution of the IPSS (total, irritative subscore, and obstructive subscore) for patients with moderate to severe LUTS at baseline.

Total IPSSIrritative IPSSObstructive IPSS

At baseline ( = 164)
 Mean ± SD14.0 ± 5.36.5 ± 2.77.5 ± 3.8
At week 24 ( = 144)
 Mean ± SD10.2 ± 4.65.0 ± 2.45.2 ± 3.1
 Change from baseline ± SD ( = NS)−3.8 ± 4.8−1.5 ± 2.4−2.3 ± 3.3
At week 48 ( = 137)
 Mean ± SD9.8 ± 5.14.8 ± 2.65.1 ± 3.3
 Change from baseline ± SD ( = NS)−3.9 ± 6.2−1.6 ± 3.1−2.3 ± 4.0
At last available visit ( = 164)
 Mean ± SD10.0 ± 5.24.8 ± 2.55.1 ± 3.3
 Change from baseline ± SD ( = NS)−4.0 ± 6.1−1.6 ± 3.0−2.4 ± 3.9